C1orf122 and hepatocellular carcinoma: Although an analysis of The Cancer Genome Atlas (TCGA) database revealed that C1orf122 is abnormally overexpressed in various cancer types, especially in HCC, non-small cell lung cancer, breast cancer, and other tumors, the specific biological function and mechanism of C1orf122 is not fully known.